Prognostic Value of Dobutamine Echocardiography Early After Uncomplicated Acute Myocardial Infarction: A Comparison With Exercise Electrocardiography  by Greco, Cosimo A et al.
Prognostic Value of Dobutamine Echocardiography Early After
Uncomplicated Acute Myocardial Infarction: A Comparison With
Exercise Electrocardiography
COSIMO A. GRECO, MD, ALESSANDRO SALUSTRI, MD, PHD, FESC,
FULVIA SECCARECCIA, MSC,* MASSIMO CIAVATTI, MD, FABIO BIFERALI, MD,
CARLO VALTORTA, MD, GIUSEPPE GUZZARDI, MD, MARIO FALCONE, MD,
ANTONIO PALAMARA, MD
Rome, Italy
Objectives. This study sought to assess the relative prognostic
power of dobutamine echocardiography and exercise electrocar-
diography after acute myocardial infarction.
Background. The prognostic value of dobutamine echocardiog-
raphy early after acute myocardial infarction has not yet been
reported.
Methods. One hundred seventy-eight patients (mean age 58 6
9 years) with a first uncomplicated acute myocardial infarction
underwent predischarge dobutamine echocardiography (5 to
40 mg/kg body weight per min, plus atropine if needed) and
symptom-limited bicycle exercise electrocardiography and were
followed up for 17 6 13 months. Stress-induced dyssynergy and
ST segment depression >1 mm were considered criteria of posi-
tivity for dobutamine echocardiography and exercise electrocar-
diography, respectively.
Results. Dobutamine echocardiography was positive in 83 pa-
tients and exercise electrocardiography in 60. At follow-up there
were 5 deaths, 6 nonfatal myocardial infarctions (11 hard events)
and 20 cases of unstable angina. Dobutamine echocardiography
and exercise electrocardiography had similar negative predictive
values both for all events (88% and 86%, respectively) and for
hard events (98% and 95%, respectively). The hard events rate was
significantly higher in patients with positive rather than negative
dobutamine echocardiography (relative risk [RR] 5.15, 95%
confidence interval [CI] 1.14 to 23.16), although there was no
difference between patients with positive and negative exercise
electrocardiograms. When Cox analysis was performed, dobut-
amine echocardiography had an independent prognostic value
both for all events (RR 2.88, 95% CI 1.37 to 6.08) and for hard
events (RR 6.56, 95% CI 1.42 to 30.46).
Conclusions. After uncomplicated acute myocardial infarction,
dobutamine echocardiography and exercise electrocardiography
have a similar high negative predictive value for both all events
and hard events only. Positive dobutamine echocardiography, but
not positive exercise electrocardiography, identifies a group of
patients at higher risk of subsequent cardiac events.
(J Am Coll Cardiol 1997;29:261–7)
q1997 by the American College of Cardiology
Survivors of uncomplicated acute myocardial infarction have a
low but definite risk for death, recurrent infarction and unsta-
ble angina. Assessing the risk of these events before hospital
discharge is extremely important for subsequent management.
The guidelines of the American College of Cardiology, Amer-
ican Heart Association and European Society of Cardiology
recommend exercise electrocardiography as the first option for
risk stratification in patients after uncomplicated acute myo-
cardial infarction (1–3). Approximately 30% of these patients
have exercise-induced ST segment depression, which has been
inconsistently related to the risk of subsequent cardiac events
(4–12).
In the recent years, echocardiography in conjunction with
different types of stress testing has been used to evaluate
patients with suspected coronary artery disease and to detect
residual myocardial ischemia in patients after acute myocardial
infarction (13–16). Dobutamine echocardiography has been
proposed and validated as a safe and accurate exercise-
simulator method for the evaluation of patients with suspected
or proven coronary artery disease (17–19). Although indica-
tions of stress echocardiography for risk stratification are
expanding (20–29), the prognostic value of dobutamine echo-
cardiography in patients early after acute myocardial infarction
has not been tested so far.
With this information in mind, we designed this study to
assess the relative prognostic power of predischarge dobut-
amine echocardiography and exercise electrocardiography in
patients after acute myocardial infarction.
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Methods
Study group. Between June 1992 and October 1995, 463
patients were consecutively admitted to our institution with a
diagnosis of acute myocardial infarction and were initially
considered for recruitment to the present study. Diagnosis of
myocardial infarction was based on a consistent history, elec-
trocardiographic (ECG) changes and cardiac enzyme level
elevations. Patients with previous myocardial infarction (n 5
121), early postinfarction angina (n 5 44), cardiac failure (n 5
38) or severe valvular heart disease (n 5 12) were excluded
from the study. Of the 248 patients fulfilling the selection
criteria, 3 had low quality baseline echocardiographic images
and could not undergo dobutamine echocardiography. Of the
remaining 245 patients, exercise electrocardiography was not
performed in 53 (18 with peripheral vascular disease, 22 with
obstructive pulmonary disease, 13 with technical reasons) and
was uninterpretable in 14 (4 with left bundle branch block, 10
with left ventricular hypertrophy). Finally, 178 patients with a
first uncomplicated acute myocardial infarction and both in-
terpretable dobutamine echocardiograms and exercise ECG
results were enrolled in a follow-up program. The character-
istics of these patients are reported in Table 1. Predischarge
dobutamine echocardiography and exercise electrocardiogra-
phy were performed 12 6 4 days from the acute myocardial
infarction, on different days and in random order. All patients
were evaluated after antianginal drugs were discontinued. The
referring cardiologist had knowledge of the results of the
noninvasive tests. However, we agreed in advance to perform
coronary angiography and eventually myocardial revasculariza-
tion procedures based on clinical grounds or on the response at
exercise electrocardiography, or because of inclusion of pa-
tients in other randomized studies.
Dobutamine echocardiography. Two-dimensional trans-
thoracic echocardiography was performed in combination with
graded dobutamine infusion after obtaining verbal informed
consent. Dobutamine was administered intravenously by an
infusion pump, starting at 5 mg/kg body weight per min for
5 min (first stage), advancing to 10 mg/kg per min for 5 min
(second stage) and increasing by 10 mg/kg per min every 3 min
up to a maximum of 40 mg/kg per min (stage 5). In patients not
achieving 85% of their gender- and age-predicted maximal
heart rate and with no symptoms or signs of myocardial
ischemia, atropine (starting with 0.25 mg, increasing to a
maximum of 1 mg) was administered intravenously at the end
of stage 5, whereas dobutamine was continued.
The test was prematurely terminated in the presence of
horizontal or downsloping ST segment depression .0.2 mV
80 ms after the J point, ST segment elevation in non-Q leads,
serious cardiac arrhythmias, significant chest pain, reduction in
systolic blood pressure .40 mm Hg from that at rest, systolic
blood pressure ,90 mm Hg, hypertension (systolic blood
pressure .220 mm Hg) or any side effect regarded as being
due to dobutamine. A new wall motion abnormality was
considered an interruption criterion only if it was severe and
extensive. Atenolol was available and used (1 to 5 mg intrave-
nously) to reverse the effects of dobutamine or dobutamine–
atropine combination if these effects did not revert spontane-
ously and quickly.
Two-dimensional echocardiography was performed with a
commercially available imaging system equipped with a 2.5-
MHz probe, and the continuously monitored images were
recorded on videotape at rest and during the final minute of
each stage.
Echocardiographic images were analyzed off-line and a con-
sensus was achieved by two cardiologists who had no knowledge
of the exercise ECG data. For the wall motion analysis, the left
ventricle was divided into 16 segments (30) and each segment
was scored using a 4-point scale: 1 5 normal; 2 5 hypokinesia;
3 5 akinesia; 4 5 dyskinesia. A wall motion score index was
derived both at rest and at peak stress by averaging the sum of
the individual’s scores by the number of the segments. A test
was considered positive in case of new or worsened wall
motion abnormalities. However, akinesia becoming dyskinesia
was not considered a criterion for positivity because this can be
due to passive stretching phenomena rather than to “active”
ischemia (31). Residual myocardial ischemia in the infarct
zone or in the remote zone was evaluated according to the
theoretic maximal risk area (32).
Exercise electrocardiography. All patients performed a
multistage, symptom-limited, upright bicycle ergometric test
with an initial load of 25 W and subsequent increments of 25 W
every 2 min. A 12-lead ECG and blood pressure were recorded
at baseline and every 2 min afterward. Criteria for interrupting
the test were severe chest pain, .0.2 mV ST segment depres-
sion, fatigue, intense dyspnea, excessive rise in blood pressure
(systolic .240 mm Hg, diastolic .120 mm Hg) or maximal
predicted heart rate.
Electrocardiographic tracings were analyzed by a cardiolo-
gist who had no knowledge of the dobutamine echocardio-
graphic results. A diagnostic criterion for myocardial ischemia
was considered the occurrence of a horizontal or downsloping
Abbreviations and Acronyms
CI 5 confidence interval
ECG 5 electrocardiogram, electrocardiographic
EPIC 5 Echocardiography Persantine International Cooperative
RR 5 relative risk
Table 1. Clinical, Electrocardiographic and Echocardiographic
Characteristics of Study Patients
Age (yr) 58 6 9
Male 158 (89%)
Thrombolytic therapy 88 (49%)
Anterior MI 78 (44%)
Inferior MI 78 (44%)
Non–Q wave MI 22 (12%)
WMSI at rest 1.4 6 0.3
Data presented are mean value 6 SD or number (%) of patients. MI 5
myocardial infarction; WMSI 5 wall motion score index.
262 GRECO ET AL. JACC Vol. 29, No. 2
DOBUTAMINE ECHOCARDIOGRAPHY AFTER MYOCARDIAL INFARCTION February 1997:261–7
ST segment shift .0.1 mV 0.08 s after the J point. The posi-
tivity of the test was defined as “low work load” if it occurred
at rate–pressure product ,20,000.
Follow-up. Follow-up data were obtained for all patients by
a staff cardiologist who visited the patients in the outpatient
clinic or who conducted a telephone interview with the patient.
The outcome events were defined as follows: cardiac death and
nonfatal myocardial infarction for “hard” event-free survival;
and cardiac death, nonfatal myocardial infarction and unstable
angina for spontaneously occurring event-free survival. A
diagnosis of unstable angina was assigned if a patient had an
exacerbation of angina resulting in hospital admission. Deaths
that occurred out of the hospital were reviewed with the family
and the patient’s physician or with the use of autopsy data.
Only the first event was considered for each patient. The
number of elective coronary artery bypass grafts or coronary
angioplasty procedures during follow-up was also recorded,
but they were not considered as cardiac events because the
decision to perform these procedures might be subjective.
However, because revascularization can affect the outcome,
follow-up in these patients was censored after the procedure.
Statistical analysis. Results are expressed as the mean
value 6 SD for continuous variables and as the percentage for
categorical variables. The agreement between exercise electro-
cardiography and dobutamine echocardiography was assessed
by calculating the kappa value. Differences between the results
of dobutamine echocardiography and exercise electrocardiog-
raphy were compared by using the chi-square test. Relative risk
(RR) and 95% confidence intervals (CI) were also calculated.
The predictive role of several variables (age, gender, hyperten-
sion, diabetes, dobutamine echocardiography and exercise
ECG results) on event-free survival was evaluated by the
stepwise procedure of the Cox regression model. Data are
expressed as chi-square, p value and RR with 95% CI. Kaplan-
Meier life-table estimates of cardiac event-free survival were
used to summarize the follow-up data of the patients, and the
differences between survival curves were tested with Mantel-
Cox test. A p value ,0.05 was considered significant.
Results
Dobutamine echocardiography. In all patients echocardio-
grams were considered interpretable during the dobutamine
stress test. Atropine was added in addition to dobutamine in 88
patients. No major side effects occurred during dobutamine
echocardiography. However, in three patients dobutamine
echocardiography was terminated before the end of the pro-
tocol and despite persistent negative echocardiographic results
owing to nonsustained ventricular tachycardia (n 5 2) or
intolerable nausea and chills (n 5 1). The test results of these
patients were included in the analysis. Wall motion score index
at rest and at peak stress was 1.46 0.3 and 1.56 0.3, respectively.
Results of dobutamine echocardiography and exercise elec-
trocardiography. The mean peak rate–pressure product was
higher with exercise than with dobutamine (24,600 6 5,070 vs.
19,0006 5,800, p, 0.001). Dobutamine echocardiography was
positive in 83 patients (47%) and negative in 95 patients
(53%). The prevalence of echocardiographic positivity was
similar in early (,8 days) versus late ($8 days) stress testing
(39% vs. 47%). Among the patients with positive results, 38
(46%) had a positive finding after atropine administration. In
48 patients, a worsening of wall motion appeared within the
infarct zone (homozonal positivity), whereas in the remaining
35 new wall motion abnormalities were found in the remote
zone (heterozonal positivity).
Exercise electrocardiography was positive in 60 (34%)
patients (at low work load in 12) and negative in 118 (66%).
The agreement between the two tests is illustrated in Figure 1.
Follow-up data. Patients were followed up for 17 6 13
months (maximal follow-up available ranged from 1 to 44
months). During the follow-up a total of 31 events occurred: 5
deaths, 6 nonfatal acute myocardial infarctions (11 hard
events) and 20 cases of unstable angina requiring hospital
admission. The events rate was similar in patients who did and
did not undergo thrombolysis (18% vs. 17%).
In Table 2, the results of dobutamine echocardiography and
exercise electrocardiography are correlated with the spontane-
ous events that occurred at follow-up evaluation. Exercise
electrocardiography and dobutamine echocardiography had a
similar negative predictive value (for spontaneous events, 86%
and 88%; and for hard events, 95% and 98%, respectively).
Figure 1. Agreement between dobutamine echocardiographic (DE)
and exercise electrocardiographic (ECG) results. 1 5 positive result;
2 5 negative result.
Table 2. Correlation Between Exercise Electrocardiographic and
Dobutamine Echocardiographic Results and Cardiac Events During
Follow-Up in the Study Group
ECG1
(n 5 60)
ECG2
(n 5 118)
DE1
(n 5 83)
DE2
(n 5 95)
No events 46 (77%) 101 (86%) 63 (76%) 84 (88%)
All events 14 (23%) 17 (14%) 20 (24%)* 11 (12%)
Hard events 5 (8%) 6 (5%) 9 (11%)† 2 (2%)
Death 2 (3%) 3 (2%) 3 (4%) 2 (2%)
Myocardial infarction 3 (5%) 3 (2%) 6 (7%)† 0 (0%)
Unstable angina 9 (15%) 11 (9%) 11 (13%) 9 (9%)
*p 5 0.05. †p , 0.01. ECG 5 exercise electrocardiography; DE 5
dobutamine echocardiography; 1 5 positive; 2 5 negative.
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The positive predictive values for spontaneous cardiac events
were 23% and 24%, respectively. Predictive values were similar
in patients who did and did not undergo thrombolysis. The
event rate was significantly higher in patients with a positive
rather than a negative dobutamine echocardiogram, for both
spontaneous (RR 2.08, 95% CI 1.06 to 4.08) and hard events
(RR 5.15, 95% CI 1.14 to 23.16), although there were no
significant differences based on the response to exercise elec-
trocardiography. In particular, considering the occurrence of
nonfatal myocardial infarction only, the event rate was 0% in
patients with negative dobutamine echocardiographic results,
and 7% in patients with dobutamine echocardiographic posi-
tivity (p 5 0.03).
In patients with either a positive exercise ECG or dobut-
amine echocardiogram, the distribution of cardiac events
according to the work load at exercise electrocardiography, the
site of myocardial ischemia and the addition of atropine during
dobutamine echocardiography is shown in Table 3. A positive
exercise ECG at a low work load did not identify patients with
a higher risk of subsequent cardiac events. For dobutamine
echocardiography, neither remote myocardial ischemia nor
positivity without atropine was found to be a predictor of
spontaneous cardiac events. However, there was a trend
toward higher hard events rate in patients with dobutamine
echocardiographic positivity without rather than with atropine
administration (16% vs. 5%).
During stepwise regression analysis, dobutamine echocar-
diographic positivity and a history of diabetes were found to
have an independent and additive value for spontaneous
events. Considering hard events, the only independent prog-
nostic factors were dobutamine echocardiographic positivity
and age (Table 4).
Kaplan-Meier life-tables of spontaneous cardiac events and
of hard event-free survival for positive or negative responses to
dobutamine echocardiography and exercise electrocardiogra-
phy are represented in Figures 2 and 3. Patients with a negative
response to dobutamine echocardiography had a significantly
higher event-free survival rate (p 5 0.01 for all events; p ,
0.005 for hard events). The time to events was similar in
patients with a positive versus a negative response to dobut-
amine echocardiography (8 6 6 vs. 10 6 9 months, respective-
ly), and in patients with homozonal versus heterozonal posi-
tivity (7 6 7 vs. 10 6 5 months, respectively).
Revascularization procedures. Forty-six revascularization
procedures (32 coronary artery bypass graft procedures and 14
percutaneous transluminal coronary angioplasties) were re-
corded during the follow-up. Of these, 15 were performed
5.9 6 2.5 months (range 3 to 12) after the acute myocardial
infarction, owing to the recurrence of angina. In the remaining
31 patients, revascularization procedures were performed
within 3 months from acute myocardial infarction based on the
results of the noninvasive tests and coronary arteriography.
These “early” revascularization procedures were performed in
22 (26%) of the 83 patients with a positive dobutamine
echocardiogram and in 15 (25%) of the 60 patients with a
positive exercise ECG.
Discussion
Patients with an uncomplicated acute myocardial infarction
have a low but definite risk of adverse outcome. In this
particular subset of patients, the optimal strategy for risk
stratification is still under debate, and all the tests applied are
partially flawed by the overall good prognosis.
The value of dobutamine echocardiography for risk strati-
fication has been already tested and confirmed in candidates
for major vascular surgery (23,24), in patients with suspected
coronary artery disease (25–28) and in patients with left
ventricular dysfunction (29). However, it is difficult to compare
Table 3. Distribution of Cardiac Events in Patients With Either a Positive Dobutamine Echocardiogram or Exercise Electrocardiogram
According to the Site of Myocardial Ischemia, Addition of Atropine During Dobutamine Echocardiography and Work Load on
Exercise Electrocardiography*
DE1 Exercise ECG1
Homozonal
(n 5 48)
Remote
(n 5 35)
Atropine
(n 5 38)
No Atropine
(n 5 45)
RPP .20,000
(n 5 48)
RPP ,20,000
(n 5 12)
All events 12 (25%) 8 (23%) 7 (18%) 13 (29%) 11 (23%) 3 (25%)
Hard events 5 (10%) 4 (11%) 2 (5%) 7 (16%) 4 (8%) 1 (8%)
Death 1 (2%) 2 (6%) 1 (3%) 2 (4%) 0 1 (8%)
Myocardial infarction 4 (8%) 2 (6%) 1 (3%) 5 (11%) 0 0
Unstable angina 7 (15%) 4 (11%) 5 (13%) 6 (13%) 2 (4%) 2 (17%)
Revascularization 15 (31%) 7 (20%) 9 (24%) 13 (19%) 11 (23%) 4 (33%)
*p5NS for all comparisons. DE5 dobutamine echocardiography; Homozonal5 ischemia in the infarct zone; remote5 ischemia at distance; RPP5 rate-pressure
product.
Table 4. Summary of the Stepwise Results Considering All
Spontaneous Recurring Events and Hard Events Only
Chi-Square p Value RR (95% CI)
All events
Positive DE 7.15 0.008 2.88 (1.37–6.08)
Diabetes 6.18 0.013 3.70 (1.50–9.17)
Hard events
Age 5.51 0.018 1.07 (1.01–1.16)
Positive DE 7.79 0.005 6.56 (1.42–30.46)
CI 5 confidence interval; DE 5 dobutamine echocardiography; Hard
events 5 cardiac death, nonfatal myocardial infarction; RR 5 relative risk.
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these studies with our study because of the limited number of
patients (26,27), the different population studied (27,28) and
the different end points considered (25,27). To the best of our
knowledge, the prognostic utility of dobutamine echocardiog-
raphy compared with established exercise electrocardiography
early after uncomplicated acute myocardial infarction has not
been specifically tested so far. Although dobutamine echocar-
diography can potentially provide prognostic information on
patients who cannot exercise, we selected only patients with
both tests interpretable for a head-to-head comparison.
Findings of present study. The results of the present study
indicate that dobutamine echocardiography is superior to
exercise electrocardiography and has independent and additive
prognostic value over clinical variables in patients who have
had an uncomplicated acute myocardial infarction. A negative
response to either dobutamine echocardiography or exercise
electrocardiography had similar predictive value for a good
outcome, both for all spontaneous events and for hard events
only. Patients with a positive dobutamine echocardiogram had
a twofold increase in spontaneous events compared with
patients with a negative dobutamine echocardiogram. Similar
values were found for exercise electrocardiography, even
though this difference did not reach statistical significance.
Considering hard events only, a positive dobutamine echocar-
diogram identified a group of patients with a fivefold increase
in risk (Table 2), whereas the response at exercise electrocar-
diography failed to identify patients with an increased risk of
future hard events. In particular, all the recurrent acute
myocardial infarctions occurred in patients with a positive
dobutamine echocardiogram, compared with the similar rate
observed in patients with a positive or negative exercise ECG.
Comparison with previous studies. Stress echocardiography
after acute myocardial infarction. The prognostic value of stress
echocardiography after acute myocardial infarction has been
already reported using either exercise (14) or dipyridamole
(22). Our results are similar to those obtained by other in-
vestigators in that exercise echocardiography identified all
patients with hard events, whereas treadmill testing alone
identified only 50% of these patients (14). The results of the
present study are also consistent with those of previous studies
showing the prognostic power of dipyridamole echocardiogra-
phy after acute myocardial infarction. In the Echo Persantine
International Cooperative (EPIC) study (22) a positive dipyr-
idamole echocardiogram and the dipyridamole time, in partic-
ular, were found to be the most important independent
predictors of future cardiac events. Positivity of dipyridamole
echocardiography in the time domain is also of prognostic
importance (22), and we found a threefold increase in the hard
events rate among patients with dobutamine echocardio-
graphic positivity without addition of atropine, which can be
Figure 2. Kaplan-Meier event-free survival curves for all spontaneous
cardiac events according to dobutamine echocardiographic (DE) (A)
and exercise electrocardiographic (ECG) (B) results. Each plot repre-
sents the cumulative proportion of patients remaining event free. 1 5
positive result; 2 5 negative result.
Figure 3. Kaplan-Meier event-free survival curves for hard events
according to dobutamine echocardiographic (DE) (A) and exercise
electrocardiographic (ECG) (B) results. Each plot represents the
cumulative proportion of patients remaining event free. 1 5 positive
result; 2 5 negative result.
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considered a low dose dobutamine stress test, compared with
patients with dobutamine echocardiographic positivity after
atropine administration. Similar to our findings, in the EPIC
study the rate of cardiac events was low, and the positive
predictive value of dipyridamole echocardiography for either
death or reinfarction was only 6%. Furthermore, Bolognese et
al. (33) found that dipyridamole echocardiography after infarc-
tion is a better predictor of recurrent ischemic events than
exercise electrocardiography. Because dobutamine and dipyr-
idamole echocardiography have shown, on average, similar
diagnostic power when applied to the same population (34,35),
it is conceivable to find a similar prognostic value.
The value of stress echocardiography for predicting recur-
rence of acute myocardial infarction has been challenged. In
theory, a physiologic approach cannot predict abrupt phenom-
ena such as plaque fissuration and thrombosis. However,
large-scale, multicenter studies indicate that the prevalence of
reinfarction is almost double in patients with positive rather
than negative stress echocardiographic results (22,36). Fur-
thermore, consistent with the findings of the present study,
Bolognese et al. (33) also found that all patients who experi-
enced acute myocardial infarction at follow-up had a positive
dipyridamole echocardiographic results. In addition, the recur-
rence of acute myocardial infarction in our patient group
occurred at a mean of 8 6 5 months (range 2 to 15) after the
index infarction, and recent data indicate that stress echocar-
diography may predict the recurrence of acute myocardial
infarction up to ;1 year (37).
Exercise electrocardiography after acute myocardial infarction.
After acute myocardial infarction, cardiac ineligibility for
exercise testing has emerged as the most powerful predictor of
recurrent ischemic events (38). In patients who can exercise,
several exercise variables (ST segment depression, angina,
exercise duration, maximal work load attained and abnormal
blood pressure response) have been inconsistently related to a
variety of clinical end points (39–42). However, to date, there
is no agreement on which of these variables can be considered
predictive of future cardiac events.
The prognostic value of ST segment depression during
exercise electrocardiography showed controversial results. Al-
though in the past decades some studies supported the value of
ST segment depression to predict a poor outcome, recently
other investigators demonstrated that mortality is correlated
with indices of ventricular dysfunction, and no ergometric
index is predictive of reinfarction (8,9,40). This disagreement
can be explained by 1) the different definitions of cardiac
events (which in some studies includes also elective coronary
revascularization); 2) the different prevalence of patients with
complicated acute myocardial infarction and poor left ventric-
ular function (in which a clinical contraindication to exercise
electrocardiography, an exercise-induced abnormal systolic
blood pressure response or a low exercise capacity are the best
predictors of adverse outcome); 3) the different prevalence of
patients with thrombolysed or non–Q wave myocardial infarc-
tion (where exercise-induced ST segment depression seems to
be associated with an increased risk (42,43); and 4) the
influence of test results on therapeutic decisions, which may
distort the relation between variables such as ST segment
depression and cardiac events. For instance, in the present
study, early coronary revascularization procedures dramati-
cally affected the outcome of the patients, thus lowering the
prognostic value of a positive test.
Study limitations. Exercise electrocardiography and do-
butamine echocardiography were analyzed using a binary
response, with ST segment depression and new or worsened
wall motion abnormalities as the only markers of a positive
test. It must be kept in mind that evaluation of other variables
(such as angina during stress testing, time of appearance or
indices of severity and extent of myocardial ischemia as change
in wall motion score index or the presence of myocardial
viability at low dose dobutamine echocardiography) may refine
the prognostic utility of the tests. Coronary angiography was
performed in a minority of patients, based on clinical indica-
tions or the results of noninvasive tests. Thus, the prognostic
value of coronary anatomy was not investigated. Finally, we
analyzed a relatively small group of patients with uncompli-
cated acute myocardial infarctions and only a few “hard”
events occurred, thus preventing “hard” conclusions about this
small group. However, this group of patients was seen at a
single intensive coronary care unit of a general hospital, and
this study has the advantage of a homogeneous reading of
dobutamine echocardiograms in a single echocardiographic
laboratory, which prevents the low interinstitutional agreement
in interpretation of stress echocardiographic readings (44).
Clinical implications. Patients with a recent uncompli-
cated acute myocardial infarction represent an important part
of all the population recovering from acute myocardial infarc-
tion. Thrombolytic therapy, beta-blockers and especially revas-
cularization procedures in those patients with signs of residual
myocardial ischemia at predischarge stress testing have re-
sulted in an overall good outcome. What is, then, the practical
prognostic benefit (if any) of predischarge dobutamine echo-
cardiography in these patients? The results of the present study
indicate that in patients with a first uncomplicated acute
myocardial infarction dobutamine echocardiography has a
high negative predictive value, similar to exercise electrocar-
diography, and discriminates the subgroup of patients with a
higher likelihood of adverse outcome. However, because of the
low positive predictive value, the clinical impact of these
results is limited. Although patients with negative dobutamine
echocardiography or exercise electrocardiography should not
need more expensive cardiac testing or invasive procedures, a
cost-effective management strategy for patients with positive
dobutamine echocardiographic results is difficult to formulate.
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